“…In particular, ecdysteroid dioxolanes such as 20-hydroxyecdysone 2,3;20,22-diacetonide were found by our group to effectively potentiate the in vitro antitumor activity of several chemotherapeutic agents including doxorubicin, paclitaxel, and vincristine, which was, however, not the case for cisplatin [ 6 ]. The strong synergistic action of certain ecdysteroids with one or more of the above-mentioned chemotherapeutics was confirmed on a broad range of cancer cell lines of various origin, including human breast (MCF-7 and its sub-cell line MCF-7 Dox adapted to doxorubicin), prostate (PC3, LNCaP), epidermal (KB-3-1 and its sub-cell line KB-C-1 adapted to colchicine), and neuroblastoma (SH-SY5Y), as well as two murine lymphoma cell lines (L5178 and its sub-cell line L5178 MDR transfected to express the human ABCB1 transporter, commonly referred to as P-glycoprotein or P-gp) [ 4 , 5 , 6 , 7 , 8 ].…”